T. Rowe Price Associates’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Buy |
25,690
+3,005
| +13% | +$26.6K | ﹤0.01% | 2659 |
|
|
2025
Q1 | $170K | Buy |
22,685
+2,120
| +10% | +$15.9K | ﹤0.01% | 2705 |
|
|
2024
Q4 | $172K | Buy |
20,565
+6,966
| +51% | +$58.3K | ﹤0.01% | 2732 |
|
|
2024
Q3 | $95K | Hold |
13,599
| – | – | ﹤0.01% | 2827 |
|
|
2024
Q2 | $67K | Buy |
13,599
+2,588
| +24% | +$12.8K | ﹤0.01% | 2816 |
|
|
2024
Q1 | $64K | Buy |
+11,011
| New | +$64K | ﹤0.01% | 2840 |
|